← SynDRA
IMAZODAN
SynDRA canonical compound SYN0000604 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | PDE3A | PDE3B |
| Mechanism of action | phosphodiesterase inhibitor |
All known targets
Mechanisms of action (all sources)
- phosphodiesterase inhibitor
- PDE5A INHIBITOR
- PDE2A INHIBITOR
- PDE3A INHIBITOR
Drug classes
- Cardiotonic Agents
- Phosphodiesterase Inhibitors
Cross-references
Synonyms
- IMAZODAN HYDROCHLORIDE
- Imazodan HCl
- CI-914
- UNII-5EP74J9Q34
- Imazodan hydrochloride [USAN]
- 4,5-Dihydro-6-(p-imidazol-1-ylphenyl)-3(2H)-pyridazinone monohydrochloride
- 5EP74J9Q34
- 4,5-Dihydro-6-(4-(1H-imidazol-1-yl)phenyl)-3(2H)-pyridazinone hydrochloride
- Imazodan hydrochloride (USAN)
- 3(2H)-Pyridazinone, 4,5-dihydro-6-(4-(1H-imidazol-1-yl)phenyl)-, monohydrochloride
- 3(2H)-Pyridazinone, 4,5-dihydro-6-(p-(1-imidazolyl)phenyl)-, monohydrochloride
- ACMC-20livl
- AC1Q3ES0
- C13H12N4O.HCl
- SCHEMBL124243
- AC1L1K29
- Imazodanum
- 6PVQ5VQW24
- DTXCID9025160
- RefChem:147927
- Imazodan [INN]
- 3-(4-imidazol-1-ylphenyl)-4,5-dihydro-1H-pyridazin-6-one
- MFCD00867109
- NCGC00015547-02
- Imazodanum [Latin]
- UNII-6PVQ5VQW24
- Cl 914
- Lopac-I-0782
- IMAZODAN [MART.]
- Lopac0_000639
- MLS000862182
- SCHEMBL148436
- orb1737750
- Imazodan, >=99% (HPLC)
- HMS2233L24
- HMS3261P20
- HMS3369I22
- Tox21_110171
Look up IMAZODAN in the interactive SynDRA portal →